Biogen Idec in MS biomarker deal with Regulus

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Biogen Idec in MS biomarker deal with Regulus

Postby MSUK » Thu Aug 16, 2012 12:30 am

Image


Biogen Idec Inc. said that it will work with Regulus Therapeutics Inc. to identify microRNAs biomarkers in patients with multiple sclerosis.

Biogen makes and sells several multiple sclerosis drugs including Avonex and Tysabri, and it is also developing BG-12, a pill that is seen as a promising treatment for the condition. The companies said Regulus believes the biomarkers may help identify the best patients for clinical trials of multiple sclerosis drugs, could be used to develop diagnostic tests and may help monitor the progression of the illness or relapses.

MicroRNAs are small RNA molecules. RNA helps synthesize proteins in the body, and microRNA helps regulate the way genes work.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1863
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2115
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service